Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-10-16

Clinical Trial Update: Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold [Phase 3]

View source ↗

Summary

Phase 3 trial of Irlanda-2 Association for common cold was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irlanda-2 Association

Snippet

Sponsor: EMS | Conditions: Common Cold | Phase 3 | Status: WITHDRAWN